BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5%
Fri, 1 Nov

BIOCON has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

BIOCON Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m13,2104,80815,722227.0%19.0%
Other incomeRs m54425338451.8%-29.4%
TurnoverRs m13,7545,06116,106218.2%17.1%
ExpensesRs m9,8144,07411,694187.0%19.2%
Gross profitRs m5,2841,5544,703202.6%-11.0%
DepreciationRs m1,1222401,316448.3%17.3%
InterestRs m18851382660.0%-26.6%
Profit before taxRs m4,5181,5623,633132.6%-19.6%
TaxRs m7323421,001192.7%36.7%
Profit after taxRs m3,7861,2202,632115.7%-30.5%
Gross profit margin%40.032.329.9
Effective tax rate%16.221.927.6
Net profit margin%27.524.116.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 19.0% on a year-on-year (YoY) basis. The expenses were up by 19.2% YoY during the same period.
  • The company's operating profit declined by 11.0% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 29.9% in 2QFY20 as against 40.0% in 2QFY19.
  • Depreciation charges increased by 17.3% and finance costs declined by 26.6% YoY, respectively.
  • Other income declined by 29.4% YoY during the quarter.
  • Net profit for the quarter declined by 30.5% YoY. Net profit margins during the quarter declined from 27.5% in 2QFY19 to 16.3% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 227.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 187.0% QoQ during the same period.
  • The company's operating profit increased by 202.6% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 29.9% in 2QFY20 as against 32.3% in 1QFY19.
  • Net profit for the quarter increased by 115.7% QoQ, while net profit margins declined from 24.1% in 1QFY19 to 16.3% in 2QFY20.

To see how BIOCON has performed over the last eight quarters,please visit here.

FLASH SALE: Grab 1 Year of Hidden Treasure for FREE...

BIOCON Share Price Performance

Over the last one year,BIOCON share price has moved down from Rs 322.6 to Rs 244.7, registering a Loss of Rs 77.9 or around 24.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,337.3 (up 0.8%). Over the last one year it has moved down from 14,632.9 to 13,337.3, a gain of 1,296 points (down 8.9%).

Overall, the S&P BSE SENSEX is up 16.6% over the year.

Current Valuations

At the current price of Rs 244.7, the price to earnings (P/E) ratio of BIOCON stands at 21.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.8 times.

Equitymaster requests your view! Post a comment on "BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5%". Click here!

  

Related Views on News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

3 Stocks to Ride the Big Rebound in Smallcaps(Profit Hunter)

Aug 11, 2020

The rebound ratio suggests that smallcaps are set for big gains but this time it will be limited to a few stocks. Make sure you choose wisely.

Governance: For the Country and Your Portfolio(The Honest Truth)

Aug 14, 2020

Ajit Dayal on the need of socially responsible governance.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Aug 14, 2020 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS